FTC Loses Lundbeck Appeal: Potential Impact on Life Science Industry Acquisition and Mergers -Francis M. Fryscak-10/04/2011 - 8:30am

Event Information
Event Topic: 
FTC Loses Lundbeck Appeal: Potential Impact on Life Science Industry Acquisition and Mergers
Event Date: 
10/04/2011 - 8:30am
Event Location: 
Sunnyvale City Council Chambers, 456 West Olive Ave., Sunnyale, CA
Speaker Information
Event Speaker: 
Francis M. Fryscak
Event Speaker Title: 
Partner (Antitrust)
Event Speaker Company: 
Cooley LLP
Event Speaker Bio: 

Francis M. Fryscak is a partner in the Antitrust & Trade Regulation practice group and a member of the Cooley LLP Business department. He joined the Firm in 1999 and is resident in the Palo Alto office.
Mr. Fryscak's practice is concentrated on antitrust matters. He provides antitrust counseling on issues arising out of mergers and acquisitions, joint ventures, distribution arrangements, price discrimination, and corporate antitrust compliance.

His recent life science transactions work has included the acquisition of Clinical Data by Forest Laboratories and the acquisition of Genoptix by Novartis.

Among his most significant matters have been such high
profile antitrust investigations as that brought in connection with Adobe Systems Incorporated's acquisition of Macromedia, Siebel Systems, Inc.'s acquisition by Oracle, and InVision Technologies acquisition by General Electric Company (GE).

Mr. Fryscak received a J.D. cum laude from New York University School of Law in 1993, where he was an associate editor for the Journal of International Law and Politics. He completed a B.A. in Politics at New York University, where he graduated in 1990 magna cum laude and as a member of Phi Beta Kappa.
He is admitted to the state bars of California, New York, Colorado, and the District of Columbia, as well as being admitted to practice before the United States District Courts for the Southern and Eastern Districts of New York and the Northern District of California. He is also a member of the American Bar Association and the New York City Bar Association. http://www.cooley.com/ffryscak

Event Details
Event Details: 

The speaker will discuss the implications of the FTC’s loss of the Lundbeck appeal, addressing the watershed impact of this, the FTC’s first ever appellate loss in a pharmaceutical merger and how it will influence life science M&A for many years to come.